hypophosphatasia

An Orbimed-backed biotech launches with $85M and plans for a new kind of DNA medicine
BioPharma Dive
Tue, 10/24/23 - 09:59 am
Rampart Biosciences
OrbiMed
Alexion Pharmaceuticals
Strensiq
hypophosphatasia
Alexion Gets U.K. Approval for High-Cost Drug
Investopedia
Sat, 09/24/16 - 01:29 pm
Alexion
UK
Strensiq
hypophosphatasia
Alexion reports data from Phase 2 study of asfotase alfa
Yahoo/Fly on the Wall
Mon, 09/23/13 - 09:39 am
Alexion
asfotase alfa
hypophosphatasia
Alexion snags latest 'breakthrough' coup with PhIII rare-disease drug
Fierce Biotech
Tue, 05/28/13 - 08:25 am
Alexion
asfotase alfa
hypophosphatasia